6
Total investments
2
Early stage
2
Mid stage
1
Late stage
10y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jun 2023
AMOpportunities equips universities and healthcare providers with the infrastructure needed to expand clinical education. AMO’s vision of accessible, inclusive, and academic clinical training inspired us to create solutions that provides this infrastructure to teaching sites and schools.
We began with a vision of quality, accessible and inclusive clinical training.
This inspired us to create comprehensive service and software solutions that help medical trainees secure rotations and support hosts and schools to manage them. In staying true to our roots, we provide high-quality support through personalized services.
Over the past 10 years, our collaboration with health systems, universities and individual trainees has helped more than 5,500 students and graduates rotate in the supported them in finding the clinical training they need to meet their academic and professional goals.
Board Observer
Dec 2022
Contact: contact@cardiosense.com
Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI to develop predictive biomarkers for pre-symptomatic disease detection and enable personalized therapy.
Board Member
Sep 2021
We provide a safe, patient-centered software platform that integrates telemedicine and patient navigation into EMS. Tele911™ provides alternatives to medically unnecessary ambulance transport of stable 911 patients to expensive, crowded hospital ERs. Learn more: https://tele911.com
Board Member
Sep 2018
Avive Solutions, Inc. is a Bay Area-based venture-backed MedTech company that has developed an award winning next-generation automated external defibrillator (AED) and software solutions in an effort to significantly increase survival rates from Sudden Cardiac Arrest. We are FDA-approved and the only AED in the industry that alerts 911. Join us on our journey to save lives.
Investor
Jan 2017
Caption Health has developed the AI platform that enables heart ultrasound access for early disease detection—when there is the highest potential for impact.
Our breakthrough Caption AI technology is the first FDA cleared AI-guided medical imaging acquisition software, enabling more healthcare professionals to capture diagnostic-quality ultrasound images in more care settings. Caption AI powers Caption Care, a turnkey echo program that offers health plans and value-based care organizations convenient and cost-effective echocardiograms for their members.
Caption Health was acquired by GE HealthCare in 2023 and has been recognized as one of TIME’s “100 Best Inventions” and Fast Company’s “Next Big Things in Tech”.
Interested in creating a world where healthcare has no limits? Check out open roles at jobs.gecareers.com/healthcare/.
Investor
Nov 2016
Moxe empowers smarter, simpler, more secure data exchange for better healthcare. Working with EHRs, health systems, and payers, Moxe improves collaboration by digitizing release of information and enabling bi-directional data exchange. Moxe’s API-first approach is revolutionizing the secure exchange of clinical information, putting actionable insights directly into the clinical workflow. Moxe solutions help optimize risk adjustment, quality improvement, payment integrity, care management, and more.
Experience · 11 entries
All (11)
Investments (6)
Board (4)
2023
Board Observer
Jun 2023
AMOpportunities equips universities and healthcare providers with the infrastructure needed to expand clinical education. AMO’s vision of accessible, inclusive, and academic clinical training inspired us to create solutions that provides this infrastructure to teaching sites and schools.
We began with a vision of quality, accessible and inclusive clinical training.
This inspired us to create comprehensive service and software solutions that help medical trainees secure rotations and support hosts and schools to manage them. In staying true to our roots, we provide high-quality support through personalized services.
Over the past 10 years, our collaboration with health systems, universities and individual trainees has helped more than 5,500 students and graduates rotate in the supported them in finding the clinical training they need to meet their academic and professional goals.
2022
Board Observer
Dec 2022
Contact: contact@cardiosense.com
Cardiosense is building a physiological waveform data platform that leverages novel multi-modal sensors and industry-leading AI to develop predictive biomarkers for pre-symptomatic disease detection and enable personalized therapy.
2021
Board Member
Sep 2021
We provide a safe, patient-centered software platform that integrates telemedicine and patient navigation into EMS. Tele911™ provides alternatives to medically unnecessary ambulance transport of stable 911 patients to expensive, crowded hospital ERs. Learn more: https://tele911.com
2020
Managing Partner
Jan 2020
The Laerdal Million Lives Fund is committed to investing in, partnering with and supporting entrepreneurs who are developing and deploying new emerging technologies capable of saving lives across the globe. We target investments in commercial stage technologies that (i) address mortality rates across clinical areas, such as maternal, neonatal, emergency medicine, critical care, surgery and others, and (ii) provide better medical education and training to providers and patients. We prioritize investments that can meaningful impact mortality rates at a global scale by improving healthcare quality and outcomes regardless of demographic or geography, thus contributing directly to our global goal of saving 1 million lives annually by 2030.
2018
Board Member
Sep 2018
Avive Solutions, Inc. is a Bay Area-based venture-backed MedTech company that has developed an award winning next-generation automated external defibrillator (AED) and software solutions in an effort to significantly increase survival rates from Sudden Cardiac Arrest. We are FDA-approved and the only AED in the industry that alerts 911. Join us on our journey to save lives.
Show all 11 entries ↓
Investment activity
2016–2023 · 6 investments
Recent (last 2 years)Earlier
